Redefining Cardiovascular Health to Include Sleep: Prospective Associations With Cardiovascular Disease in the MESA Sleep Study

Nour Makarem*, Cecilia Castro-Diehl, Marie Pierre St-Onge, Susan Redline, Steven Shea, Donald Lloyd-Jones, Hongyan Ning, Brooke Aggarwal

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

75 Scopus citations

Abstract

BACKGROUND: Although sufficient and healthy sleep is inversely associated with cardiovascular disease (CVD) and its risk fac-tors, the American Heart Association’s Life’s Simple 7 (LS7), as a measure of cardiovascular health (CVH), did not include sleep. We evaluated an expanded measure of CVH that includes sleep as an eighth metric in relation to CVD risk. METHODS AND RESULTS: The analytic sample consisted of MESA (Multi-Ethnic Study of Atherosclerosis) Sleep Study participants who had complete data on sleep characteristics from overnight polysomnography, 7-day wrist actigraphy, validated questionnaires, and the outcome. We computed the LS7 score and 4 iterations of a new CVH score: score 1 included sleep duration, score 2 included sleep characteristics linked to CVD in the literature (sleep duration, insomnia, daytime sleepiness, and obstructive sleep apnea), scores 3 and 4 included sleep characteristics associated with CVD in MESA (score 3: sleep duration and efficiency, daytime sleepiness, and obstructive sleep apnea; score 4: score 3+sleep regularity). Multivariable-adjusted logistic and Cox proportional hazards models evaluated associations of the LS7 and CVH scores 1 to 4 with CVD prevalence and incidence. Among 1920 participants (mean age: 69±9 years; 54% female), there were 95 prevalent CVD events and 93 incident cases (mean follow-up, 4.4 years). Those in the highest versus lowest tertile of the LS7 score and CVH scores 1 to 4 had up to 80% lower odds of prevalent CVD. The LS7 score was not significantly associated with CVD incidence (hazard ratio, 0.62 [95% CI, 0.37–1.04]). Those in the highest versus lowest tertile of CVH score 1, which included sleep duration, and CVH score 4, which included multidimensional sleep health, had 43% and 47% lower incident CVD risk (hazard ratio, 0.57 [95% CI, 0.33– 0.97]; and hazard ratio, 0.53 [95% CI, 0.32– 0.89]), respectively. CONCLUSIONS: CVH scores that include sleep health predicted CVD risk in older US adults. The incorporation of sleep as a CVH metric, akin to other health behaviors, may enhance CVD primordial and primary prevention efforts. Findings warrant confirmation in larger cohorts over longer follow-up.

Original languageEnglish (US)
Article numbere025252
JournalJournal of the American Heart Association
Volume11
Issue number21
DOIs
StatePublished - Nov 1 2022

Funding

MESA is conducted and supported by the National Heart, Lung, and Blood Institute in collaboration with MESA investigators. Support for MESA is provided by contracts HHSN268201500003I, N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169, UL1-TR-000040, UL1-TR-001079, UL1-TR-001881, and DK06349. Funding for the MESA Sleep Exam was by grant HL098433. Dr Makarem is supported by National Heart, Lung, and Blood Institute Grant R00-HL148511; and American Heart Association Grant #AHA855050. Dr St-Onge was funded by National Institutes of Health Grants R01HL128226 and R01HL142648. Dr Redline was funded by National Heart, Lung, and Blood Institute R35 HL135818. Dr Aggarwal is supported by an American Heart Association Research Goes Red Award (Grant #AHA811531).

Keywords

  • Life’s Essential 8
  • Life’s Simple 7
  • cardiovascular diseases
  • cardiovascular health
  • health behaviors
  • primordial prevention
  • sleep

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Redefining Cardiovascular Health to Include Sleep: Prospective Associations With Cardiovascular Disease in the MESA Sleep Study'. Together they form a unique fingerprint.

Cite this